Core Viewpoint - A lawsuit is pending against Charming Medical Limited (NASDAQ: MCTA) for alleged violations of securities laws, with a deadline for affected investors to act by February 17, 2026 [1]. Group 1: Lawsuit Details - An investor filed a lawsuit on December 22, 2025, claiming that Charming Medical made false and misleading statements and failed to disclose involvement in a fraudulent stock promotion scheme [2]. - The lawsuit alleges that insiders and affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign [2]. - It is claimed that Charming Medical's public statements and risk disclosures did not mention the false rumors and artificial trading activity that influenced the stock price [2]. Group 2: Investor Actions - Investors who purchased shares of Charming Medical Limited are encouraged to contact the Shareholders Foundation for assistance [3]. - The Shareholders Foundation provides legal monitoring and settlement claim filing services related to shareholder issues and securities class actions [3].
Investors who lost money with Charming Medical Limited (NASDAQ: MCTA) should contact the Shareholders Foundation in connection with Lawsuit